Literature DB >> 15700946

Irritable bowel syndrome. 10% to 20% of older adults have symptoms consistent with diagnosis.

Eli D Ehrenpreis1.   

Abstract

Although irritable bowel syndrome (IBS) is a common disorder, IBS is traditionally considered to be a condition that primarily affects young and middle-aged adults. However, increasing evidence suggests that prevalence of IBS in older adults may be similar to that in younger adults; therefore, the diagnosis should be considered when a geriatric patient presents with unexplained abdominal symptoms. Because incidences of other conditions with similar symptoms are higher in the geriatric population, use of certain diagnostic tests (eg, colonoscopy) is warranted in this patient population. In addition, because older adults are more likely than younger adults to suffer from comorbid conditions, polypharmacy is common in this patient population, and this should be considered when diagnosing and treating these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700946

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  4 in total

1.  Genetic diversity contributes to abnormalities in pain behaviors between young and old rats.

Authors:  A Chaloner; Beverley Greenwood-Van Meerveld
Journal:  Age (Dordr)       Date:  2011-11-18

2.  Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study.

Authors:  Anil Minocha; William D Johnson; Thomas L Abell; William Chad Wigington
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

3.  Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age.

Authors:  Elyse R Thakur; Brian M Quigley; Hashem B El-Serag; Gregory D Gudleski; Jeffrey M Lackner
Journal:  J Psychosom Res       Date:  2016-07-16       Impact factor: 3.006

4.  Increased prevalence of gastrointestinal symptoms in patients with allergic disease.

Authors:  Nick Powell; Benedict Huntley; Thomas Beech; William Knight; Hannah Knight; Christopher J Corrigan
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.